×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Videos
Maps
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Sun Pharma Acquires Concert Pharma For $576 Mil
BW Businessworld
A definitive deal has been signed by Sun Pharmaceutical Industries, the fourth-largest specialty generic pharmaceutical firm in the world,...
14 hours ago
Sun Pharma Acquires Concert Pharmaceuticals
Contract Pharma
Sun Pharmaceutical Industries Ltd. acquired Concert Pharmaceuticals, Inc., a late-stage clinical biopharmaceutical company developing...
11 months ago
Sun Pharma to Acquire Concert Pharmaceuticals, Advancing the Potential Treatment of Alopecia Areata
Business Wire
(NASDAQ: CNCE) (“Concert”) today announced that they have executed a definitive agreement under which Sun Pharma will acquire all outstanding...
15 months ago
Sun Pharma's Hair-Loss Treatment Patent Axed at Federal Circuit
Bloomberg Law News
The Federal Circuit backed an administrative tribunal's decision to invalidate a Sun Pharmaceutical Industries Inc. patent for a hair-loss...
8 months ago
Sun Pharma Completes Acquisition of Concert Pharmaceuticals
PR Newswire
"By bringing together Concert's talented team with Sun Pharma's global reach and commercial capabilities, this acquisition is an opportunity to...
13 months ago
US appeals court denies Sun Pharma patent for alopecia treatment
Life Sciences Intellectual Property Review
Indian drugmaker had challenged PTAB decision that patent for new version of ruxolitinib was invalid as obvious | Decision hands a victory...
8 months ago
Sun's $576M Concert hits bum note as FDA imposes partial hold
Fierce Biotech
Sun Pharma's $576 million Concert Pharmaceuticals buyout has rapidly run onto the rocks. Two months after closing the deal,...
12 months ago
Sun Pharmaceutical Industries Acquires Concert Pharma for $576M
PharmaNewsIntel
India's top pharmaceutical company will acquire Massachusetts-based Concert Pharmaceuticals and its experimental drug for alopecia. ... February...
14 months ago
India's Sun Pharma acquires U.S.-based Concert for $576 mln
Reuters
Sun Pharmaceutical Industries Limited , India's largest drugmaker, said on Thursday it will acquire U.S.-based Concert Pharmaceuticals for...
15 months ago
Buy Sun Pharmaceutical Industries; target of Rs 1640: Prabhudas Lilladher
Moneycontrol
Prabhudas Lilladher is bullish on Sun Pharmaceutical Industries has recommended buy rating on the stock with a target price of Rs 1640 in...
2 months ago